Kuzhuvelil B Harikumar

10PUBLICATIONS
23CO-AUTHORS
Molecular targetsInnate immunityNanomedicinePredictive and prognostic markersCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 16, 2026
Uttroside B, a US FDA-designated 'Orphan Drug', mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3.

|Mar 29, 2024
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy.

Yadu Vijayan, Jaskirat Singh Sandhu, Kuzhuvelil B Harikumar

|Apr 28, 2023
Integrative Analysis of the AMPK subunits in Colorectal Adeno Carcinoma.

Beena T B, Jesil Mathew A, Harikumar K B

|May 28, 2022
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma.

Mundanattu Swetha, Chenicheri K Keerthana, Tennyson P Rayginia

|Apr 23, 2022
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management.

Claudia Arndt, Ralf Bergmann, Franziska Striese

|Feb 09, 2022
DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer.

Hetakshi Kurani, Seyedeh Fatemeh Razavipour, Kuzhuvelil B Harikumar

Pageof 2

Frequent Collaborators

2 joint publications

Jesil Mathew A

2 joint publications

Nikhil Ponnoor Anto

2 joint publications

Mundanattu Swetha

1 joint publications

Seyedeh Fatemeh Razavipour